US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
GB0121980D0
(en)
|
2001-09-11 |
2001-10-31 |
Cathnet Science Holding As |
Expandable stent
|
US20030135266A1
(en)
|
2001-12-03 |
2003-07-17 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US7351255B2
(en)
|
2001-12-03 |
2008-04-01 |
Xtent, Inc. |
Stent delivery apparatus and method
|
US7137993B2
(en)
|
2001-12-03 |
2006-11-21 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US20040186551A1
(en)
|
2003-01-17 |
2004-09-23 |
Xtent, Inc. |
Multiple independent nested stent structures and methods for their preparation and deployment
|
US7294146B2
(en)
|
2001-12-03 |
2007-11-13 |
Xtent, Inc. |
Apparatus and methods for delivery of variable length stents
|
US7182779B2
(en)
|
2001-12-03 |
2007-02-27 |
Xtent, Inc. |
Apparatus and methods for positioning prostheses for deployment from a catheter
|
US8080048B2
(en)
|
2001-12-03 |
2011-12-20 |
Xtent, Inc. |
Stent delivery for bifurcated vessels
|
US7147656B2
(en)
|
2001-12-03 |
2006-12-12 |
Xtent, Inc. |
Apparatus and methods for delivery of braided prostheses
|
US7892273B2
(en)
|
2001-12-03 |
2011-02-22 |
Xtent, Inc. |
Custom length stent apparatus
|
US7309350B2
(en)
|
2001-12-03 |
2007-12-18 |
Xtent, Inc. |
Apparatus and methods for deployment of vascular prostheses
|
US7084153B2
(en)
*
|
2002-04-12 |
2006-08-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments comprising steroids and a novel anticholinergic
|
US7241308B2
(en)
*
|
2003-06-09 |
2007-07-10 |
Xtent, Inc. |
Stent deployment systems and methods
|
US7553324B2
(en)
*
|
2003-10-14 |
2009-06-30 |
Xtent, Inc. |
Fixed stent delivery devices and methods
|
US7220755B2
(en)
*
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
US7326236B2
(en)
|
2003-12-23 |
2008-02-05 |
Xtent, Inc. |
Devices and methods for controlling and indicating the length of an interventional element
|
EP1571151B1
(de)
*
|
2004-03-01 |
2008-12-24 |
Terumo Kabushiki Kaisha |
Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten
|
US7323006B2
(en)
|
2004-03-30 |
2008-01-29 |
Xtent, Inc. |
Rapid exchange interventional devices and methods
|
US20050288766A1
(en)
|
2004-06-28 |
2005-12-29 |
Xtent, Inc. |
Devices and methods for controlling expandable prostheses during deployment
|
US8317859B2
(en)
|
2004-06-28 |
2012-11-27 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US20060034884A1
(en)
*
|
2004-08-10 |
2006-02-16 |
Stenzel Eric B |
Coated medical device having an increased coating surface area
|
US7901451B2
(en)
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
US8221824B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Boston Scientific Scimed, Inc. |
Deforming surface of drug eluting coating to alter drug release profile of a medical device
|
US7402168B2
(en)
*
|
2005-04-11 |
2008-07-22 |
Xtent, Inc. |
Custom-length stent delivery system with independently operable expansion elements
|
US20090062909A1
(en)
|
2005-07-15 |
2009-03-05 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
PL1909973T3
(pl)
|
2005-07-15 |
2019-01-31 |
Micell Technologies, Inc. |
Polimerowe powłoki zawierające proszek leku o kontrolowanej morfologii
|
US7622477B2
(en)
*
|
2006-02-28 |
2009-11-24 |
Cordis Corporation |
Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
|
US8652198B2
(en)
|
2006-03-20 |
2014-02-18 |
J.W. Medical Systems Ltd. |
Apparatus and methods for deployment of linked prosthetic segments
|
ES2540059T3
(es)
|
2006-04-26 |
2015-07-08 |
Micell Technologies, Inc. |
Recubrimientos que contienen múltiples fármacos
|
US20070281117A1
(en)
|
2006-06-02 |
2007-12-06 |
Xtent, Inc. |
Use of plasma in formation of biodegradable stent coating
|
US20080269865A1
(en)
*
|
2006-08-07 |
2008-10-30 |
Xtent, Inc. |
Custom Length Stent Apparatus
|
US20110034503A1
(en)
*
|
2006-08-22 |
2011-02-10 |
Ruey-Shiuan Tsai |
Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders
|
WO2008033956A2
(en)
|
2006-09-13 |
2008-03-20 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US8088789B2
(en)
|
2006-09-13 |
2012-01-03 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US10695327B2
(en)
|
2006-09-13 |
2020-06-30 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
US20080097591A1
(en)
*
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
US20080103584A1
(en)
*
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
JP5456321B2
(ja)
*
|
2006-11-27 |
2014-03-26 |
テルモ株式会社 |
O−アルキル化ラパマイシン誘導体の製造方法およびo−アルキル化ラパマイシン誘導体
|
JP5603598B2
(ja)
|
2007-01-08 |
2014-10-08 |
ミセル テクノロジーズ、インコーポレイテッド |
生物分解層を有するステント
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
US20080199510A1
(en)
|
2007-02-20 |
2008-08-21 |
Xtent, Inc. |
Thermo-mechanically controlled implants and methods of use
|
US9888924B2
(en)
|
2007-03-06 |
2018-02-13 |
Covidien Lp |
Wound closure material
|
US8486132B2
(en)
|
2007-03-22 |
2013-07-16 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
US8573150B2
(en)
*
|
2007-11-14 |
2013-11-05 |
Biosensors International Group, Ltd. |
Automated stent coating apparatus and method
|
US9101503B2
(en)
|
2008-03-06 |
2015-08-11 |
J.W. Medical Systems Ltd. |
Apparatus having variable strut length and methods of use
|
US20110098241A1
(en)
*
|
2008-04-14 |
2011-04-28 |
Poniard Pharmaceuticals, Inc. |
Rapamycin analogs as anti-cancer agents
|
CA2721832C
(en)
|
2008-04-17 |
2018-08-07 |
Micell Technologies, Inc. |
Stents having bioabsorbable layers
|
US20100055145A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Biosensors International Group |
Stent coatings for reducing late stent thrombosis
|
US11298252B2
(en)
|
2008-09-25 |
2022-04-12 |
Advanced Bifurcation Systems Inc. |
Stent alignment during treatment of a bifurcation
|
EP2344068B1
(de)
|
2008-09-25 |
2022-10-19 |
Advanced Bifurcation Systems Inc. |
Teilweise gekrimpter stent
|
US8828071B2
(en)
|
2008-09-25 |
2014-09-09 |
Advanced Bifurcation Systems, Inc. |
Methods and systems for ostial stenting of a bifurcation
|
US8821562B2
(en)
|
2008-09-25 |
2014-09-02 |
Advanced Bifurcation Systems, Inc. |
Partially crimped stent
|
EP2365802B1
(de)
|
2008-11-11 |
2017-08-02 |
The Board of Regents,The University of Texas System |
Mikrokapseln von rapamycin und deren verwendung zur behandlung von krebs
|
CN102481195B
(zh)
|
2009-04-01 |
2015-03-25 |
米歇尔技术公司 |
涂覆支架
|
EP2453834A4
(de)
|
2009-07-16 |
2014-04-16 |
Micell Technologies Inc |
Medizinische wirkstofffreisetzungsvorrichtung
|
US8381774B2
(en)
*
|
2009-09-20 |
2013-02-26 |
Medtronic Vascular, Inc. |
Methods for loading a drug eluting medical device
|
US9283211B1
(en)
|
2009-11-11 |
2016-03-15 |
Rapamycin Holdings, Llc |
Oral rapamycin preparation and use for stomatitis
|
WO2011097103A1
(en)
|
2010-02-02 |
2011-08-11 |
Micell Technologies, Inc. |
Stent and stent delivery system with improved deliverability
|
EP2549951B1
(de)
|
2010-03-24 |
2017-05-10 |
Advanced Bifurcation Systems, Inc. |
Stentausrichtung während der behandlung einer bifurkation
|
CA2794064A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
Methods and systems for treating a bifurcation with provisional side branch stenting
|
WO2011119884A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc |
System and methods for treating a bifurcation
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
US10232092B2
(en)
|
2010-04-22 |
2019-03-19 |
Micell Technologies, Inc. |
Stents and other devices having extracellular matrix coating
|
EP2593039B1
(de)
|
2010-07-16 |
2022-11-30 |
Micell Technologies, Inc. |
Medizinische wirkstofffreisetzungsvorrichtung
|
CN103140494A
(zh)
*
|
2010-08-04 |
2013-06-05 |
美利奴生命科学有限公司 |
制备具有抗增殖特性的新的42-o-(杂烷氧基烷基)雷帕霉素化合物的方法
|
US8632846B2
(en)
*
|
2010-09-17 |
2014-01-21 |
Medtronic Vascular, Inc. |
Apparatus and methods for loading a drug eluting medical device
|
WO2012081429A1
(ja)
|
2010-12-16 |
2012-06-21 |
住友精化株式会社 |
擬ポリロタキサンの製造方法
|
CA2821905C
(en)
|
2010-12-16 |
2018-07-10 |
Sumitomo Seika Chemicals Co., Ltd. |
Method for producing pseudopolyrotaxane aqueous dispersion
|
KR101840505B1
(ko)
*
|
2010-12-16 |
2018-03-20 |
스미또모 세이까 가부시키가이샤 |
정제 폴리로탁산의 제조 방법
|
EP2653482B1
(de)
|
2010-12-16 |
2015-09-30 |
Sumitomo Seika Chemicals Co. Ltd. |
Verfahren zur herstellung von pseudopolyrotaxan
|
CA2826760A1
(en)
|
2011-02-08 |
2012-08-16 |
Advanced Bifurcation Systems, Inc. |
Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
|
EP2672932B1
(de)
|
2011-02-08 |
2018-09-19 |
Advanced Bifurcation Systems, Inc. |
System zur behandlung einer gabelung mit einem vollständig gecrimpten stent
|
WO2012124217A1
(ja)
*
|
2011-03-14 |
2012-09-20 |
住友精化株式会社 |
粉末状親水性修飾ポリロタキサンの製造方法
|
WO2012124219A1
(ja)
*
|
2011-03-14 |
2012-09-20 |
住友精化株式会社 |
ポリロタキサン組成物
|
US9409999B2
(en)
*
|
2011-03-14 |
2016-08-09 |
Sumitomo Seika Chemicals Co., Ltd. |
Production method for hydrophilic modified polyrotaxane
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
EP2589383A1
(de)
|
2011-11-06 |
2013-05-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin |
FKBP-subtypspezifisches Rapamycin-Analogon zur Verwendung bei der Behandlung von Erkrankungen
|
CA2868123A1
(en)
|
2012-03-23 |
2013-09-26 |
The University Of Queensland |
Immunomodulatory agent and uses therefor
|
EP2832750A4
(de)
*
|
2012-03-30 |
2015-11-04 |
Ube Industries |
Verfahren zur herstellung von hydroxyalkyliertem polyrotaxan
|
US9364273B2
(en)
*
|
2012-08-15 |
2016-06-14 |
DePuy Synthes Products, Inc. |
Drug eluting surgical screw
|
CN110123759A
(zh)
|
2012-12-03 |
2019-08-16 |
曼丽国际有限公司 |
Umirolimus及其衍生物用于治疗癌症的用途
|
EP2948460B1
(de)
*
|
2013-01-22 |
2017-07-19 |
Biosensors International Group, Ltd. |
Niedrigtemperatursynthese von rapamycinderivaten
|
EP2967803B1
(de)
*
|
2013-03-12 |
2023-12-27 |
Micell Technologies, Inc. |
Bioabsorbierbare biomedizinische implantate
|
EP2968281B1
(de)
|
2013-03-13 |
2020-08-05 |
The Board of Regents of The University of Texas System |
Mtor-hemmer zur vorbeugung von darmpolypenwachstum
|
EP2972258B1
(de)
|
2013-03-15 |
2021-08-04 |
Biosensors International Group, Ltd. |
Reinigung von rapamycinderivaten
|
JP2016519965A
(ja)
|
2013-05-15 |
2016-07-11 |
マイセル・テクノロジーズ,インコーポレイテッド |
生体吸収性バイオメディカルインプラント
|
US20150073998A1
(en)
|
2013-09-09 |
2015-03-12 |
Apple Inc. |
Use of a Biometric Image in Online Commerce
|
KR20160084438A
(ko)
|
2013-11-13 |
2016-07-13 |
노파르티스 아게 |
면역 반응을 강화하기 위한 mTOR 억제제
|
CA3225453A1
(en)
|
2013-12-19 |
2015-06-25 |
Novartis Ag |
Human mesothelin chimeric antigen receptors and uses thereof
|
US10287354B2
(en)
|
2013-12-20 |
2019-05-14 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
US9700544B2
(en)
|
2013-12-31 |
2017-07-11 |
Neal K Vail |
Oral rapamycin nanoparticle preparations
|
CA3206208A1
(en)
|
2013-12-31 |
2015-07-09 |
Rapamycin Holdings, Llc |
Oral rapamycin nanoparticle preparations and use
|
US20170081411A1
(en)
|
2014-03-15 |
2017-03-23 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
US20170335281A1
(en)
|
2014-03-15 |
2017-11-23 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor
|
SG10202109752XA
(en)
|
2014-04-07 |
2021-10-28 |
Novartis Ag |
Treatment of cancer using anti-cd19 chimeric antigen receptor
|
US10329386B2
(en)
*
|
2014-07-08 |
2019-06-25 |
Osaka University |
Self-restoring macromolecular material and production method for same
|
AU2015292755B2
(en)
|
2014-07-21 |
2020-11-12 |
Novartis Ag |
Treatment of cancer using a CD33 chimeric antigen receptor
|
US11542488B2
(en)
|
2014-07-21 |
2023-01-03 |
Novartis Ag |
Sortase synthesized chimeric antigen receptors
|
JP2017528433A
(ja)
|
2014-07-21 |
2017-09-28 |
ノバルティス アーゲー |
低い免疫増強用量のmTOR阻害剤とCARの組み合わせ
|
EP3174546B1
(de)
|
2014-07-31 |
2019-10-30 |
Novartis AG |
Teilmengenoptimierte chimäre antigenrezeptorhaltige t-zellen
|
US10851149B2
(en)
|
2014-08-14 |
2020-12-01 |
The Trustees Of The University Of Pennsylvania |
Treatment of cancer using GFR α-4 chimeric antigen receptor
|
MY189028A
(en)
|
2014-08-19 |
2022-01-20 |
Novartis Ag |
Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
|
CN107073066B
(zh)
|
2014-09-11 |
2021-09-17 |
加利福尼亚大学董事会 |
mTORC1抑制剂
|
AU2015317608B2
(en)
|
2014-09-17 |
2021-03-11 |
Novartis Ag |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
CN114107424A
(zh)
|
2014-10-08 |
2022-03-01 |
诺华股份有限公司 |
预测针对嵌合抗原受体疗法的治疗应答性的生物标志及其用途
|
US20180334490A1
(en)
|
2014-12-03 |
2018-11-22 |
Qilong H. Wu |
Methods for b cell preconditioning in car therapy
|
US11161907B2
(en)
|
2015-02-02 |
2021-11-02 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
US20180140602A1
(en)
|
2015-04-07 |
2018-05-24 |
Novartis Ag |
Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
|
JP7114457B2
(ja)
|
2015-04-17 |
2022-08-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
キメラ抗原受容体発現細胞の有効性および増殖を改善するための方法
|
EP3286211A1
(de)
|
2015-04-23 |
2018-02-28 |
Novartis AG |
Behandlung von krebs mit chimärem antigenrezeptor- und proteinkinase-a-blocker
|
CN107847491A
(zh)
|
2015-05-20 |
2018-03-27 |
诺华公司 |
依维莫司(everolimus)与达托里昔布(dactolisib)的医药组合
|
TW201708538A
(zh)
|
2015-07-21 |
2017-03-01 |
諾華公司 |
改良免疫細胞之功效及擴展之方法
|
CA3001654A1
(en)
|
2015-11-11 |
2017-05-18 |
Novartis Ag |
Uses of myostatin antagonists, combinations containing them and uses thereof
|
US20200281973A1
(en)
|
2016-03-04 |
2020-09-10 |
Novartis Ag |
Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore
|
CN110225927B
(zh)
|
2016-10-07 |
2024-01-12 |
诺华股份有限公司 |
用于治疗癌症的嵌合抗原受体
|
AU2017363970A1
(en)
|
2016-11-23 |
2019-06-20 |
Novartis Ag |
Methods of enhancing immune response with everolimus, dactolisib or both
|
US20200055948A1
(en)
|
2017-04-28 |
2020-02-20 |
Novartis Ag |
Cells expressing a bcma-targeting chimeric antigen receptor, and combination therapy with a gamma secretase inhibitor
|
EP3624863B1
(de)
|
2017-05-15 |
2021-04-14 |
C.R. Bard, Inc. |
Medizinische vorrichtung mit wirkstofffreisetzender beschichtung und zwischenschicht
|
US10596165B2
(en)
|
2018-02-12 |
2020-03-24 |
resTORbio, Inc. |
Combination therapies
|
US20210047405A1
(en)
|
2018-04-27 |
2021-02-18 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
CA3098692A1
(en)
|
2018-05-01 |
2019-11-07 |
Revolution Medicines, Inc. |
C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors
|
MX2020011564A
(es)
|
2018-05-01 |
2021-01-29 |
Revolution Medicines Inc |
Analogos de rapamicina unidos a c26 como inhibidores de mtor.
|
EP3788369A1
(de)
|
2018-05-01 |
2021-03-10 |
Novartis Ag |
Biomarker zur auswertung von car-t-zellen zur vorhersage des klinischen ergebnisses
|
EP3813946B1
(de)
|
2018-06-15 |
2024-05-22 |
Janssen Pharmaceutica NV |
Rapamycinanaloga und verwendungen davon
|
EP3880266A1
(de)
|
2018-11-14 |
2021-09-22 |
Lutonix, Inc. |
Medizinische vorrichtung mit wirkstofffreisetzender beschichtung auf modifizierter vorrichtungsoberfläche
|
EP3952937A1
(de)
|
2019-04-08 |
2022-02-16 |
Bard Peripheral Vascular, Inc. |
Medizinische vorrichtung mit wirkstofffreisetzender beschichtung auf modifizierter vorrichtungsoberfläche
|
US11517457B2
(en)
*
|
2019-07-03 |
2022-12-06 |
Abbott Cardiovascular Systems Inc. |
Intravascular stent
|
BR112022010754A2
(pt)
*
|
2019-12-05 |
2022-08-23 |
Anakuria Therapeutics Inc |
Análogos de rapamicina e usos dos mesmos
|